Answer
Its UK licence covers selected adults with symptomatic heart failure and reduced ejection fraction who have recently required intravenous treatment for decompensation and are now stabilised.
Sources for this answer
- Verquvo 10 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 2